Featured 13F manager
Omega Advisors Leon Cooperman
Boca Raton, FL 22 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.5B
- 39 Positions
- 2026 Q2
- +16.4% QoQ
- Top 5 47.8%
Portfolio
top 5 47.8% · top 10 68.4%
- VRT - Vertiv · CL A 20.4%
- RKT - Rocket Cos · CL A 9.3%
- ET - Energy Transfer 7.2%
- FIHL - Fidelis Insurance 5.8%
- GPGI — · CL A 5.1%
- MP - Mp Materials · CL A 4.7%
- APO - Apollo Global Management 4.5%
- MIR - Mirion Technologies · CL A 4.2%
- OMF - Onemain 3.7%
- ASH - Ashland 3.5%
- WSC - Willscot · CL A 3.3%
- LAD - Lithia Motors 2.8%
- Other 25.5%
AUM over time
Book
| RKT - Rocket Cos · CL A | 13.50% | New | 21,016,600 | $19.36 | $407M | +21,016,600 | +$407M |
| VRT - Vertiv · CL A | 11.60% | Hold | 2,157,789 | $162.01 | $350M | — | — |
| ET - Energy Transfer | 7.29% | Add +1.7% | 13,320,100 | $16.49 | $220M | +225,100 | −$5M |
| MIR - Mirion Technologies · CL A | 6.51% | Hold | 8,383,441 | $23.42 | $196M | — | — |
| APO - Apollo Global Management | 6.42% | Hold | 1,337,000 | $144.76 | $194M | — | — |
| MP - Mp Materials · CL A | 5.03% | Hold | 3,000,000 | $50.52 | $152M | — | — |
| FIHL - Fidelis Insurance | 4.57% | Add +5.7% | 7,041,751 | $19.57 | $138M | +379,282 | +$17M |
| ELV - Elevance Health | 3.96% | Hold | 340,900 | $350.55 | $120M | — | — |
| LAD - Lithia Motors | 3.50% | Hold | 317,602 | $332.33 | $106M | — | — |
| ASH - Ashland | 3.31% | Hold | 1,700,000 | $58.67 | $100M | — | — |
| RRX - Regal Rexnord | 3.21% | Reduce −6.2% | 690,000 | $140.32 | $97M | −45,766 | −$9M |
| CI - The Cigna Group | 2.97% | Hold | 325,000 | $275.23 | $89M | — | — |
| KBR - KBR Inc | 2.83% | Add +21.4% | 2,125,000 | $40.20 | $85M | +375,000 | +$3M |
| SUN - Sunoco | 2.82% | Hold | 1,620,000 | $52.41 | $85M | — | — |
| WSC - Willscot · CL A | 2.52% | Hold | 4,031,016 | $18.83 | $76M | — | — |
| GEHC - GE HealthCare | 1.82% | Add +11.7% | 670,000 | $82.02 | $55M | +70,000 | +$10M |
| MSI - Motorola Solutions | 1.72% | Hold | 135,000 | $383.32 | $52M | — | — |
| AESI - Atlas Energy Solutions | 1.58% | Reduce −5.8% | 5,053,474 | $9.42 | $48M | −312,889 | −$13M |
| AMRZ - Amrize | 1.58% | Hold | 880,000 | $54.08 | $48M | — | — |
| OMF - Onemain | 1.57% | Reduce −16.6% | 700,000 | $67.55 | $47M | −139,000 | −$85K |
| MANU - Manchester United · CL A | 1.54% | Add +2.2% | 2,922,076 | $15.92 | $47M | +64,199 | +$3M |
| EPD - Enterprise Products | 1.46% | Add +3.8% | 1,373,755 | $32.06 | $44M | +50,120 | +$3M |
| SE - SEA | 1.38% | Hold | 326,058 | $127.57 | $42M | — | — |
| STKL - Sunopta | 1.14% | Add +35.8% | 9,053,300 | $3.80 | $34M | +2,386,191 | −$5M |
| GCI - USA Today | 1.05% | Add +5.1% | 6,164,811 | $5.15 | $32M | +297,602 | +$8M |
| FOA - Finance Of America Cos · CL A | 1.03% | Hold | 1,286,040 | $24.21 | $31M | — | — |
| OXY - Occidental | 0.96% | Add +107.4% | 700,000 | $41.12 | $29M | +362,500 | +$13M |
| VOO - Vanguard Index Fds | 0.91% | Hold | 43,593 | $627.13 | $27M | — | — |
| GOOGL - Alphabet · CL A | 0.78% | Hold | 75,000 | $313.00 | $23M | — | — |
| DMAC - Diamedica Therapeutics | 0.53% | Reduce −38.2% | 2,020,000 | $7.96 | $16M | −1,249,761 | −$2M |
| ABR - Arbor Realty Trust | 0.40% | Reduce −8.2% | 1,560,000 | $7.76 | $12M | −140,000 | −$9M |
| EFA - Ishares Tr | 0.18% | Hold | 57,453 | $96.03 | $6M | — | — |
| IEUR - Ishares Tr | 0.09% | Hold | 38,388 | $70.98 | $3M | — | — |
| VXUS - Vanguard Intl Equity Index | 0.07% | Hold | 24,693 | $83.61 | $2M | — | — |
| VGIT - Vanguard Scottsdale Fds | 0.05% | Hold | 25,028 | $59.93 | $1M | — | — |
| EWJ - Ishares | 0.04% | Hold | 14,305 | $80.74 | $1M | — | — |
| EWC - Ishares | 0.02% | Hold | 12,531 | $53.93 | $676K | — | — |
| VTEB - Vanguard Mun Bd Fds | 0.02% | Hold | 12,876 | $50.29 | $648K | — | — |
| EPP - Ishares | 0.01% | Hold | 7,610 | $50.47 | $384K | — | — |
| FLCA - Franklin Templeton ETF Tr | 0.01% | Hold | 5,750 | $48.30 | $278K | — | — |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Mr Cooper Group | 18.82% | Exit | 0 | $210.79 | $603M | −2,860,600 | −$603M |
| AVBP - Arrivent Biopharma | 0.24% | Exit | 0 | $18.45 | $8M | −421,278 | −$8M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 39 | $3.5B | +16.4% | 13F-HR | 8/14/2026 | 000094562126001056 |
| 2026 Q1 | 41 | $3B | +1.1% | 13F-HR | 5/15/2026 | 000094562126000719 |
| 2025 Q4 | 40 | $3B | −5.9% | 13F-HR | 2/17/2026 | 000094562126000329 |
| 2025 Q3 | 41 | $3.2B | +12.6% | 13F-HR | 11/14/2025 | 000094562125001130 |
| 2025 Q2 | 40 | $2.8B | +14.0% | 13F-HR | 8/14/2025 | 000094562125000771 |
| 2025 Q1 | 41 | $2.5B | — | RESTATEMENT | 5/15/2025 | 000094562125000506 |
| 2025 Q1 | 40 | $2.5B | −5.6% | 13F-HR | 5/15/2025 | 000094562125000492 |
| 2024 Q4 | 45 | $2.6B | +12.2% | 13F-HR | 2/14/2025 | 000094562125000191 |
| 2024 Q3 | 40 | $2.4B | −0.7% | 13F-HR | 11/14/2024 | 000094562124000945 |
| 2024 Q2 | 52 | $2.4B | −1.3% | 13F-HR | 8/14/2024 | 000094562124000673 |
| 2024 Q1 | 51 | $2.4B | +14.2% | 13F-HR | 5/15/2024 | 000094562124000434 |
| 2023 Q4 | 50 | $2.1B | — | RESTATEMENT | 2/14/2024 | 000094562124000256 |
| 2023 Q4 | 50 | $2.1B | +10.0% | 13F-HR | 2/14/2024 | 000094562124000254 |
| 2023 Q3 | 54 | $1.9B | +3.6% | 13F-HR | 11/14/2023 | 000094562123000579 |
| 2023 Q2 | 54 | $1.8B | +11.0% | 13F-HR | 8/30/2023 | 000094562123000457 |
| 2023 Q1 | 55 | $1.7B | +3.1% | 13F-HR | 8/30/2023 | 000094562123000460 |
| 2022 Q4 | 56 | $1.6B | +13.1% | 13F-HR | 8/30/2023 | 000094562123000462 |
| 2022 Q3 | 57 | $1.4B | −2.1% | 13F-HR | 8/31/2023 | 000094562123000466 |
| 2022 Q2 | 53 | $1.5B | −23.4% | 13F-HR | 8/31/2023 | 000094562123000468 |
| 2022 Q1 | 54 | $1.9B | −4.6% | 13F-HR | 8/31/2023 | 000094562123000470 |
| 2021 Q4 | 56 | $2B | +5.6% | 13F-HR | 2/14/2022 | 000156761922003846 |
| 2021 Q3 | 65 | $1.9B | — | 13F-HR | 11/15/2021 | 000156761921020244 |
About
Omega Advisors
SEC: COOPERMAN LEON G
22 processed 13Fs on this site · 2021 Q3–2026 Q2